文献速递脑血管病

炎症性肠病患者的长期卒中风险:一项基于人群的同胞对照队列研究,1969-2019年

Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease: A Population-Based, Sibling-Controlled Cohort Study, 1969-2019.
PubMed 文献 · Neurology · 2023-06-14

这项基于瑞典人群的同胞对照队列研究纳入1969至2019年活检确诊的炎症性肠病(IBD)患者85,006例、匹配参考个体406,987例及无IBD全职同胞101,082例,发现IBD患者卒中风险升高(aHR 1.13,95%CI 1.08-1.17),以缺血性卒中为主,且风险在诊断后25年仍持续升高。

要点

  • IBD患者总体卒中风险升高(aHR 1.13,95%CI 1.08-1.17),缺血性卒中风险升高(aHR 1.14,95%CI 1.09-1.18)。
  • 出血性卒中风险未见显著升高(aHR 1.06,95%CI 0.97-1.15)。
  • 风险升高在各IBD亚型中均可见,且诊断后25年仍持续存在。

核心结论

  • IBD患者卒中风险升高,尤其是缺血性事件,且不限于IBD亚型,这种超额风险在诊断后25年仍持续存在。

研究设计与样本

  • 基于瑞典人群的同胞对照队列研究,纳入1969至2019年活检确诊的IBD患者85,006例(克罗恩病25,257例、溃疡性结肠炎47,354例、IBD未分型12,395例)、匹配参考个体406,987例及无IBD全职同胞101,082例。

主要发现

  • IBD患者发生3,720例卒中(发病率32.6/10,000人年),参考个体发生15,599例(发病率27.7/10,000人年),aHR 1.13(95%CI 1.08-1.17)。
  • 诊断后25年超额风险仍升高,相当于每93例IBD患者至该时点增加1例卒中。
  • 缺血性卒中aHR 1.14(95%CI 1.09-1.18),出血性卒中aHR 1.06(95%CI 0.97-1.15)。
  • 缺血性卒中风险在各亚型均显著升高:克罗恩病发病率23.3 vs 19.2,aHR 1.19(95%CI 1.10-1.29);溃疡性结肠炎发病率25.7 vs 22.6,aHR 1.09(95%CI 1.04-1.16);IBD未分型发病率30.5 vs 22.8,aHR 1.22(95%CI 1.08-1.37)。
  • IBD患者与同胞比较得到相似结果。

临床怎么用

  • 作者认为,这些发现强调临床需对IBD患者脑血管事件的长期超额风险保持警惕。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Patients with inflammatory bowel disease (IBD) are at an increased risk of thromboembolic events, but evidence on the long-term risk of stroke remains scarce. We aimed to explore whether patients with a biopsy-confirmed IBD had an increased long-term risk of stroke. METHODS: This cohort included all patients with biopsy-confirmed IBD in Sweden between 1969 and 2019 and up to 5 matched reference individuals per patient who were randomly selected from the general population and IBD-free full siblings. The primary outcome was incident overall stroke; secondary outcomes were ischemic and hemorrhagic strokes. Stroke was identified from the Swedish National Patient Register by using both primary and secondary diagnoses. Adjusted hazard ratios (aHRs) for stroke were estimated by flexible parametric survival models. RESULTS: A total of 85,006 patients with IBD (including Crohn disease [CD, n = 25,257], ulcerative colitis [UC, n = 47,354], and IBD-unclassified [IBD-U, n = 12,395]), 406,987 matched reference individuals, and 101,082 IBD-free full siblings were included in the analysis. We observed 3,720 incident strokes in patients with IBD (incidence rate [IR] 32.6 per 10,000 person-years) and 15,599 in reference individuals (IR 27.7; aHR 1.13, 95% CI 1.08-1.17). The elevated aHR remained increased even 25 years after diagnosis, corresponding to 1 additional stroke case per 93 patients with IBD until then. The excess aHR was mainly driven by ischemic stroke (aHR 1.14; 1.09-1.18) rather than hemorrhagic stroke (aHR 1.06; 0.97-1.15). The risk of ischemic stroke was significantly increased across IBD subtypes (CD [IR 23.3 vs 19.2; aHR 1.19; 1.10-1.29], UC [IR 25.7 vs 22.6; aHR 1.09; 1.04-1.16], and IBD-U [IR 30.5 vs 22.8; aHR 1.22; 1.08-1.37]). Similar results were found when patients with IBD were compared with their siblings. DISCUSSION: Patients with IBD were at an increased risk of stroke, especially of ischemic events, irrespective of the IBD subtype. The excess risk persisted even 25 years after diagnosis. These findings highlight the need for clinical vigilance about the long-term excess risk of cerebrovascular events in patients with IBD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sun J, Halfvarson J, Appelros P, et al. Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease: A Population-Based, Sibling-Controlled Cohort Study, 1969-2019. Neurology. 2023. PMID: 37316347. doi:10.1212/WNL.0000000000207480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。